Literature DB >> 21258894

Effect of Chinese drugs combining with chemotherapy on quality of life in 146 children with solid tumor.

Xue Shi1, Li Tian, Xiu-Dan Zhu, Huan-Min Wang, Hong Qin.   

Abstract

OBJECTIVE: To explore the effect of Chinese drugs for supporting essence and strengthening Pi ( SESP) combining with chemotherapy on the quality of life (QOL) in the children with solid tumor.
METHODS: Using a digital table, 146 children with solid tumor were randomized into two groups, 77 in the control group and 69 in the treated group. They received conventional chemotherapy, but to the patients in the treated group, SESP were administered additionally. The patients' scores of QOL and adverse reaction occurred were compared.
RESULTS: The states in the treated group were superior to those in the control group. Statistical analysis showed that in the first year, the two groups were different in terms of somatic function, systemic symptoms, and general status (P<0.05) and also in the occurrence of adverse reaction (P<0.01). In the second year, the difference was shown in aspects of somatic function and adverse reaction occurrence (P<0.05).
CONCLUSION: Chinese drugs for SESP combining with chemotherapy could raise tumor patients' QOL by improving their somatic function and clinical symptoms.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258894     DOI: 10.1007/s11655-011-0608-3

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  1 in total

1.  The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making.

Authors:  James W Varni; Michael Seid; Tara Smith Knight; Karen Uzark; Ilona S Szer
Journal:  J Behav Med       Date:  2002-04
  1 in total
  1 in total

1.  High-dose chemotherapy combined with autologous peripheral blood stem cell transplantation in children with advanced malignant solid tumors: A retrospective analysis of 38 cases.

Authors:  Wei-Ling Zhang; Y I Zhang; Tian Zhi; Dong-Sheng Huang; Yi-Zhuo Wang; Liang Hong; Xia Zhu; Ai-Ping Liu; Hui-Min Hu
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.